SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
SGTX
Delisted
SGTX was delisted on the 10th of August, 2023.
16 hedge funds and large institutions have $26.6M invested in Sigilon Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 9 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
89% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 9
Holders
16
Holding in Top 10
1
Calls
$293K
Puts
–
Top Buyers
| 1 | +$895K | |
| 2 | +$299K | |
| 3 | +$23.3K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3K |
Top Sellers
| 1 | -$1.81M | |
| 2 | -$823K | |
| 3 | -$283K | |
| 4 |
Millennium Management
New York
|
-$259K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$133K |